UK markets closed

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.46000.0000 (0.00%)
At close: 02:10PM EDT
Show:
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
14,993
12,415
5,479
244
0
Cost of revenue
8,194
7,456
3,762
-
-
Gross profit
6,799
4,959
1,717
-
-
Operating expenses
Research development
30,910
30,765
20,209
13,336
9,743
Selling general and administrative
22,025
20,008
13,983
9,642
10,828
Total operating expenses
53,194
50,773
34,192
22,978
20,571
Operating income or loss
-46,395
-45,814
-32,475
-22,734
-20,571
Interest expense
-523
8
16
33
-
Total other income/expenses net
-
-44
-3,679
-130
6
Income before tax
-45,558
-45,856
-36,041
-22,870
-20,526
Income tax expense
-6,884
-6,446
-3,494
-3,288
-2,115
Income from continuing operations
-38,674
-39,410
-32,547
-19,582
-18,411
Net income
-38,674
-39,410
-32,547
-19,582
-18,411
Net income available to common shareholders
-38,674
-39,410
-32,547
-19,582
-18,411
Basic EPS
-
-0.44
-0.40
-0.26
-0.26
Diluted EPS
-
-0.44
-0.40
-0.26
-0.26
Basic average shares
-
88,950
81,776
75,127
70,313
Diluted average shares
-
88,950
81,776
75,127
70,313
EBITDA
-
-45,421
-35,529
-22,355
-20,172